Global Blood Therapeutics, Inc.

GBT · NASDAQ
Analyze with AI
6/30/2022
3/31/2022
12/31/2021
9/30/2021
Assets
Cash & Equivalents$261,152$391,803$684,717$382,869
Short-Term Investments$256,006$161,614$0$3,205
Receivables$29,765$27,730$28,800$23,894
Inventory$65,816$61,964$58,202$51,512
Other Curr. Assets$27,272$32,537$30,251$27,384
Total Curr. Assets$640,011$675,648$801,970$488,864
Property Plant & Equip (Net)$78,922$80,869$82,933$84,147
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$146,863$108,667$50,057$30,692
Tax Assets$0$0$0$0
Other NC Assets$4,646$4,359$4,248$3,975
Total NC Assets$230,431$193,895$137,238$118,814
Other Assets$0$0$0$0
Total Assets$870,442$869,543$939,208$607,678
Liabilities
Payables$8,260$5,422$15,097$8,642
Short-Term Debt$6,119$5,891$5,670$5,454
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$78,713$67,992$67,231$59,962
Total Curr. Liab.$93,092$79,305$87,998$74,058
LT Debt$652,267$653,160$653,947$224,498
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$6,723$3,076$853$822
Total NC Liab.$658,990$656,236$654,800$225,320
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$752,082$735,541$742,798$299,378
Equity
Pref Stock$0$0$0$0
Common Stock$67$65$65$64
Retained Earnings-$1,453,453-$1,370,983-$1,289,560-$1,201,979
AOCI-$3,973-$1,962$100$221
Other Equity$1,575,719$1,506,882$1,485,805$1,509,994
Total Equity$118,360$134,002$196,410$308,300
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$870,442$869,543$939,208$607,678
Net Debt$397,234$267,248-$25,100-$152,917